Article metrics
Other content recommended for you
- Neuroenhancers, addiction and research ethics
- Neuropsychiatry of the basal ganglia
- True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- Sugar addiction: is it real? A narrative review
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Psychostimulant effect of levodopa: reversing sensitisation is possible
- The use of methylphenidate among students: the future of enhancement?
- A selective literature review exploring the role of the nicotinic system in schizophrenia
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology